Clinical trials
Adult clinical trials
Below are recruiting adult clinical trials, each written for real people, not researchers. We’re tracking 3,745 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07598409Recruiting
Brain Training Program for Older Adults in Spain
This study tests whether a computer-based brain training program can help older adults maintain or improve their thinking and memory skills. Researchers will compare people with normal thinking abilities to those with mild memory problems to see if the training helps both groups.
Madrid, MadridAges 65 years+ - NCT06717828Recruiting
Tai Chi for fatty liver in older adults
This trial tests whether Tai Chi, a gentle exercise, can improve fatty liver disease in middle-aged and older adults who are overweight. If you are between 40 and 75 and have metabolic fatty liver, you might be able to join.
Fuzhou, FujianAges 40–75 - NCT06719024RecruitingPhase 2/Phase 3
Ruxolitinib cream for vitiligo on face and neck
This trial tests a cream called ruxolitinib for adults with vitiligo on the face and neck that has not responded well to another cream (tacrolimus). The goal is to see if this cream can help bring back skin color.
Hong KongAges 18–85 - NCT07594093RecruitingPhase 1
A study of REGN20934 for adults with overweight or obesity
This trial tests a new medication, REGN20934, to see how safe it is and how it works in the body for adults who are overweight or have obesity. It may help if you are looking for new treatment options.
Glendale, CaliforniaAges 18–65 - NCT07592585RecruitingPhase 3
Testing VC005 cream for mild-to-moderate eczema in teens and adults
This study tests a new medication called VC005 to treat atopic dermatitis (eczema)—a skin condition causing itching, redness, and inflammation. Researchers want to see if VC005 can safely reduce symptoms in people aged 12 and older with mild-to-moderate cases.
Nanjing, JiangsuAges 12 years+ - NCT07594106RecruitingPhase 1/Phase 2
New immunotherapy for advanced prostate or kidney cancer
This trial tests new experimental drugs (REGN15505 and REGN4336) designed to target and attack cancer cells in advanced prostate cancer or kidney cancer. These drugs work by boosting your immune system to recognize and destroy cancer, and may be combined with other approved immunotherapy drugs.
Goodyear, ArizonaAges 18 years+ - NCT07589608RecruitingPhase 2
Weight Loss Study With Two New Injectable Medications
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
Chandler, ArizonaAges 18–75 - NCT07589257RecruitingPhase 2
VRT106 drug combined with radiation for brain stem tumors
This trial tests whether a new drug called VRT106, given alongside radiation therapy, can help treat a serious type of brain tumor called diffuse midline glioma or DIPG. The drug is designed to work with radiation to fight the cancer.
Guangzhou, GuangdongAges 18–75 - NCT07594847RecruitingPhase 1
Safety study of HDM1002 tablets on heart rhythm in healthy adults
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
Zibo, ShangdongAges 18–45 - NCT07587021RecruitingPhase 2
YOLT-203 treatment study for primary hyperoxaluria type 1
This study tests a new drug called YOLT-203 for people with primary hyperoxaluria type 1 (PH1), a rare genetic condition where the body produces too much oxalate, which can damage the kidneys. The trial aims to see if this drug can help reduce oxalate levels and prevent kidney damage.
Birmingham, AlabamaAges 6 years+ - NCT07589231Recruiting
Carbon Fiber Insoles for Athletic Jump and Sprint Performance
This study tests whether special insoles with carbon fiber improve how high you can jump and how fast you can sprint. Researchers want to see if these insoles help healthy young athletes perform better.
Valencia, ValenciaAges 18–30 - NCT07591571Recruiting
Digital support program for newly diagnosed pancreatic cancer
This study tests a digital support program led by community health workers for people recently diagnosed with pancreatic adenocarcinoma (a type of pancreatic cancer). The program aims to help patients navigate their diagnosis and treatment.
Loma Linda, CaliforniaAges 1.5 years+ - NCT07589114Recruiting
Sleep technology to improve mood and well-being
This study tests a technology designed to enhance REM sleep (the stage where you dream) to help improve your mood, emotions, and overall quality of life. Researchers want to see if better sleep quality can boost your well-being.
Târgu Mureş, Mureș CountyAges 18 years+ - NCT07592975Recruiting
Food with Fiber and B-Vitamins for Gut Health in Older Adults
This study tests whether adding special fibers (prebiotics) and B-vitamins to food can improve your gut bacteria, reduce inflammation, and support mental health. You'll eat fortified foods for several weeks while researchers track changes in your digestion and wellbeing.
Coleraine, County LondonderryAges 50 years+ - NCT07590635Recruiting
Heart Recovery Program Using Online Health Tools
This study tests a new heart rehabilitation program that combines online tools with personalized support for people who've had heart procedures. It aims to help you recover safely and manage your heart health from home.
BergenAges 18 years+ - NCT07594600Recruiting
Fiber Diet Effects on Breath Compounds in Healthy Adults
This study examines how different amounts of dietary fiber affect natural chemical compounds released in your breath. Researchers will measure these compounds to understand how fiber influences your gut health and digestion.
ÖrebroAges 18–65 - NCT07594613Recruiting
Family study of resting metabolic rate in parents and adult children
This study looks at how your body burns energy at rest (resting metabolic rate) and whether it is similar between parents and their adult children. If you are part of a parent-child pair, you may be able to help researchers learn more about family patterns in metabolism.
Tel AvivAges 18–60 - NCT07593677Recruiting
Text Messages to Help You Move More
This study tests whether personalized text messages can motivate adults to exercise more. You'll receive encouraging texts over 6 months and track your activity to see if texting helps you stay active.
Ann Arbor, MichiganAges 40 years+ - NCT07593859Recruiting
Brain Stimulation Research Study for Healthy Adults
This study tests a new non-invasive brain stimulation technique called transcranial temporal interference stimulation. Researchers want to understand how to make it work better and safer in humans.
Boston, MassachusettsAges 18–65 - NCT07591649RecruitingPhase 1/Phase 2
NK cells for high-risk blood cancers before transplant
This study tests a new type of immune cell therapy (called AdaptNK cells) for patients with high-risk myeloid diseases (blood cancers affecting bone marrow cells) who are preparing for a stem cell transplant. The goal is to help control the cancer and prepare your body for the transplant.
Minneapolis, MinnesotaAges 18 years+ - NCT07594821Recruiting
Two approaches to carpal tunnel surgery: comparing outcomes
This study compares two surgical approaches for carpal tunnel syndrome—one that releases pressure on the median nerve in one location versus releasing it in two locations. The goal is to find out which approach works better for relieving symptoms like numbness and tingling in the hand.
Rotterdam, South HollandAges 18 years+ - NCT07588022Recruiting
How Your Body Reacts to Jägermeister Mixed with Energy Drinks
This study examines what happens to your heart, blood pressure, and overall health when you drink Jägermeister (a digestif liqueur) mixed with energy drinks. Researchers want to understand the physical effects of combining alcohol and high-caffeine beverages in healthy young adults.
BarcelonaAges 18–45 - NCT07592676Recruiting
Moving from pediatric to adult epilepsy care
This study looks at how young people with epilepsy transition from pediatric (children's) specialists to adult neurologists. Researchers want to understand what helps or challenges this transition to improve the care experience.
RomaAges 15 years+ - NCT07587944Recruiting
Blood Markers to Predict AML Treatment Response
This study looks at special markers in bone marrow fluid to predict how well chemotherapy will work for newly diagnosed acute myeloid leukemia (AML). By identifying these markers early, doctors may be able to choose the best treatment plan for each patient.
Fuzhou, FujianAges 18 years+
Hear when a new Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adult?
- Yes. Clin2 currently lists 3,745 recruiting adult studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adult trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adult trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.